The design of accurate and robust analytical methodology is instrumental to developing orally inhaled and nasal drug products (OINDPs) and their appropriate control programmes.
Mary Ann Smith
Advertisement
Articles by Mary Ann Smith
Advertisement
Latest Updated Articles
Quality by Design for analytical methods for use with orally inhaled and nasal drug productsPublished: October 1st 2008 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
AAPS PharmSci 360 2025: Trends in Bioanalysis
2
AAPS PharmSci 360 2025: The Role of LC–MS in Bioanalysis
3
PharmTech Weekly News Roundup – Week of November 3, 2025
4
How AI, Machine Learning, and Large Language Models Enhance Bioanalysis
5
